Alexander William Thoman, DO | |
6161 S Yale Ave, Tulsa, OK 74136-1902 | |
(918) 502-1900 | |
(918) 494-6303 |
Full Name | Alexander William Thoman |
---|---|
Gender | Male |
Speciality | Hospitalist |
Experience | 6 Years |
Location | 6161 S Yale Ave, Tulsa, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558866970 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 6775 (Oklahoma) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Saint Francis Hospital, Inc | Tulsa, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Warren Clinic Inc | 8820900293 | 604 |
News Archive
Bristol-Myers Squibb has announced the submission of a New Drug Application to the U.S. Food and Drug Administration for entecavir, an investigational antiviral agent under development for the treatment of chronic Hepatitis B.
A new study published online June 8 in the Nature publication, Molecular Psychiatry, indicates that postnatal exposure to thimerosal, a mercury preservative commonly used in a number of childhood vaccines, can lead to the development of autism-like damage in autoimmune disease susceptible mice
Announcing a new article publication for Zoonoses journal. In this commentary researchers from Beijing Minhai Biotechnology Co., Ltd., Beijing, China, Hubei Provincial Center for Disease Control and Prevention, Wuhan, China, Guangdong Provincial Institute of Biological Products and Drugs, Guangzhou, China, Gaozhou Center for Disease Control and Prevention, Guangdong, China and the Yangchun Center for Disease Control and Prevention, Guangdong, China consider immungenicity and cross-neutralizing activity of enterovirus 71 vaccine candidate strains.
All ten patients are doing well after a rare 5-way kidney swap transplant at California Pacific Medical Center in San Francisco, part of the Sutter Health network.
XenoPort, Inc. announced today preliminary top-line results of a Phase 2, randomized, crossover clinical trial that compared optimized treatment with either Sinemet (immediate-release levodopa/carbidopa) or XP21279 co-formulated with carbidopa (279/CD) in advanced Parkinson's disease patients with motor fluctuations.
› Verified 5 days ago
Entity Name | Warren Clinic Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174582282 PECOS PAC ID: 8820900293 Enrollment ID: O20031104000252 |
News Archive
Bristol-Myers Squibb has announced the submission of a New Drug Application to the U.S. Food and Drug Administration for entecavir, an investigational antiviral agent under development for the treatment of chronic Hepatitis B.
A new study published online June 8 in the Nature publication, Molecular Psychiatry, indicates that postnatal exposure to thimerosal, a mercury preservative commonly used in a number of childhood vaccines, can lead to the development of autism-like damage in autoimmune disease susceptible mice
Announcing a new article publication for Zoonoses journal. In this commentary researchers from Beijing Minhai Biotechnology Co., Ltd., Beijing, China, Hubei Provincial Center for Disease Control and Prevention, Wuhan, China, Guangdong Provincial Institute of Biological Products and Drugs, Guangzhou, China, Gaozhou Center for Disease Control and Prevention, Guangdong, China and the Yangchun Center for Disease Control and Prevention, Guangdong, China consider immungenicity and cross-neutralizing activity of enterovirus 71 vaccine candidate strains.
All ten patients are doing well after a rare 5-way kidney swap transplant at California Pacific Medical Center in San Francisco, part of the Sutter Health network.
XenoPort, Inc. announced today preliminary top-line results of a Phase 2, randomized, crossover clinical trial that compared optimized treatment with either Sinemet (immediate-release levodopa/carbidopa) or XP21279 co-formulated with carbidopa (279/CD) in advanced Parkinson's disease patients with motor fluctuations.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Alexander William Thoman, DO 6600 S Yale Ave Ste 1200, Tulsa, OK 74136-3361 Ph: (918) 488-6653 | Alexander William Thoman, DO 6161 S Yale Ave, Tulsa, OK 74136-1902 Ph: (918) 502-1900 |
News Archive
Bristol-Myers Squibb has announced the submission of a New Drug Application to the U.S. Food and Drug Administration for entecavir, an investigational antiviral agent under development for the treatment of chronic Hepatitis B.
A new study published online June 8 in the Nature publication, Molecular Psychiatry, indicates that postnatal exposure to thimerosal, a mercury preservative commonly used in a number of childhood vaccines, can lead to the development of autism-like damage in autoimmune disease susceptible mice
Announcing a new article publication for Zoonoses journal. In this commentary researchers from Beijing Minhai Biotechnology Co., Ltd., Beijing, China, Hubei Provincial Center for Disease Control and Prevention, Wuhan, China, Guangdong Provincial Institute of Biological Products and Drugs, Guangzhou, China, Gaozhou Center for Disease Control and Prevention, Guangdong, China and the Yangchun Center for Disease Control and Prevention, Guangdong, China consider immungenicity and cross-neutralizing activity of enterovirus 71 vaccine candidate strains.
All ten patients are doing well after a rare 5-way kidney swap transplant at California Pacific Medical Center in San Francisco, part of the Sutter Health network.
XenoPort, Inc. announced today preliminary top-line results of a Phase 2, randomized, crossover clinical trial that compared optimized treatment with either Sinemet (immediate-release levodopa/carbidopa) or XP21279 co-formulated with carbidopa (279/CD) in advanced Parkinson's disease patients with motor fluctuations.
› Verified 5 days ago
Prasoon Kumar Yendluri, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6161 S Yale Ave, Tulsa, OK 74136 Phone: 918-502-1900 Fax: 918-494-6303 | |
Janet Elizabeth Cheek, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave, Ste 460, Tulsa, OK 74104 Phone: 918-579-5749 Fax: 918-579-5762 | |
Edie Ann Carey, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave, Ste 460, Tulsa, OK 74104 Phone: 918-579-5749 Fax: 918-579-5762 | |
Dr. Brandon Micheal Bailey, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2811 E 15th St Ste 102, Tulsa, OK 74104 Phone: 918-935-3240 Fax: 918-935-3241 | |
Kendra Wilson, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 6161 S Yale Ave, Tulsa, OK 74136 Phone: 918-502-1900 Fax: 918-494-6303 | |
Radhika Kothakota, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6161 S Yale Ave, Tulsa, OK 74136 Phone: 918-488-6045 Fax: 918-488-6098 | |
Dr. Gulshan Dangol, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave Ste 460, Tulsa, OK 74104 Phone: 918-579-5749 Fax: 918-579-5762 |